Familial ApoB-specific familial hypobetalipoproteinemia in a patient with non-classical congenital adrenal hyperplasia
Clin Investig Arterioscler. 2024 May-Jun;36(3):128-132.
doi: 10.1016/j.arteri.2023.12.002.
Epub 2024 Jan 8.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Endocrinología y Nutrición, Complejo Asistencial Universitario de León, Castilla-León, España. Electronic address: beatriz.ramos.bachiller@gmail.com.
- 2 Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Madrid, España; Grupo de Investigación en Diabetes, Obesidad y Reproducción Humana, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), CIBER de Diabetes y Enfermedades Metabólicas asociadas, y Universidad de Alcalá, Madrid, España.
- 3 Department of Genetics of Metabolic Diseases, Instituto de Genética Médica y Molecular (INGEMM), Hospital Universitario La Paz, Madrid, España.
- 4 Servicio de Endocrinología y Nutrición, Hospital Universitario Ramón y Cajal, Madrid, España; Centro de Referencia Nacional (CSUR) y Europeo (MetabERN) para Enfermedades Metabólicas Hereditarias, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, España.
Abstract
Familial hypobetalipoproteinaemia is a disorder of lipid metabolism characterized by low levels of total cholesterol, low-density lipoprotein cholesterol and apolipoprotein B. ApoB-related familial hypolipoproteinemia is an autosomal condition with a codominance inheritance pattern. Non-classical congenital adrenal hyperplasia is an autosomal recessive disorder due to mutations in the CYP21A2, a gene encoding for the enzyme 21-hydroxylase, which results in an androgen excess production from adrenal source. We here present the case of a 25-year-old woman with NCAH showing decreased levels of total-cholesterol, low-density lipoprotein cholesterol and triglycerides. Her parent had digestive symptoms and severe hepatic steatosis with elevated liver enzymes, as well as decreased levels of total and low-density lipoprotein cholesterol. A genetic-molecular study of the proband identified a mutation in the APOB gene, which allowed a diagnosis of heterozygous ApoB-related hypolipoproteinaemia to be made.
Keywords:
21-Hydroxylase; 21-hidroxilasa; APOB gene; CYP21A2; Familial hypobetalipoproteinaemia; Gen APOB; Hiperplasia suprarrenal congénita no clásica; Hipobetalipoproteinemia familiar; Non-classical congenital adrenal hyperplasia.
Copyright © 2023 Sociedad Española de Arteriosclerosis. Publicado por Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Adrenal Hyperplasia, Congenital* / complications
-
Adrenal Hyperplasia, Congenital* / genetics
-
Adult
-
Apolipoproteins B* / genetics
-
Cholesterol / blood
-
Cholesterol, LDL* / blood
-
Fatty Liver / genetics
-
Female
-
Heterozygote
-
Humans
-
Hypobetalipoproteinemia, Familial, Apolipoprotein B* / genetics
-
Mutation*
-
Steroid 21-Hydroxylase / genetics
-
Triglycerides / blood
Substances
-
Apolipoproteins B
-
Cholesterol, LDL
-
Cholesterol
-
Triglycerides
-
Steroid 21-Hydroxylase
-
CYP21A2 protein, human